Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Notes:
See 'General notes for interpreting data' on the Explanatory notes and help page.
Sources:
Adapted from Matheï, C., Buntinx, F. & Damme, P. Van (2002). Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review. Journal of Viral Hepatitis 9 (3), 157-173.